Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In New Zealand, 1 in 3 adults has obesity, a rate which has been increasing for decades
43% of adults who have diabetes say they have used GLP-1 medications
Acute stress and large meals trigger GLP-1 in the brain to suppress appetite, preventing overeating
If you experience any side effects, including constipation, you can report them directly to the MHRA Yellow Card Scheme at yellowcard
During phase 1 trials in NASH patients, efocipegtrutide showed a half-life of around 5.9 days, and was capable of reducing body weight by 5.1% when administered weekly at 0.08mg/kg, after 12 weeks [36]
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
